Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalYu Sawada, Tetsuya Nakatsura, Toshimitsu Kuronuma et al.|Clinical Cancer Research|2012Cited by 299